Clinical Trial Update: Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating trastuzumab added to first-line chemotherapy versus chemotherapy alone for HER2-positive advanced biliary tract cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Biliary Tract Cancer, HER2-positive Cancer | Phase 3 | Status: RECRUITING